Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,201 trials

NCT07045194
Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
Not applicable · United States · 22 sites
Registry update: 22 Oct 2026
NCT07223021
Recruiting
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Phase 3 · Germany, Spain, Netherlands, United States · 9 sites
Registry update: 5 Nov 2026
NCT06845319
Recruiting
NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
Phase 2 · United States · 1 site
Registry update: 6 May 2026
NCT07104604
Recruiting
Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Phase 2 · China · 2 sites
Registry update: 24 Jul 2026
NCT07431021
Recruiting
Children's Health, Respiratory Inflammation and Short-term Air Pollution
Not applicable · United Kingdom · 1 site
Registry update: 15 Jun 2026
NCT07191353
Recruiting
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Phase 2 · Denmark · 2 sites
Registry update: 6 Apr 2026
NCT07444801
Recruiting
Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Not applicable · Germany · 2 sites
Registry update: 3 Mar 2026
NCT07285850
Recruiting
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
Phase 2/3 · China · 1 site
Registry update: 16 Dec 2025
NCT07288684
Recruiting
Chiropractor Delivered Virtual Intervention After Vertebral frActure
Not applicable · Canada · 1 site
Registry update: 17 Dec 2025
NCT07775820
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
Not applicable · China · 5 sites
Registry update: 20 Aug 2026
NCT07213609
Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Phase 1/2 · Canada, Denmark, Spain, France, Italy, Japan, Netherlands, Sweden, United States · 22 sites
Registry update: 16 Sept 2026
NCT07407465
Recruiting
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
Phase 2 · Germany, Spain, France, Italy · 29 sites
Registry update: 17 Feb 2026
NCT07176468
Recruiting
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
Not applicable · China · 1 site
Registry update: 30 Dec 2025
NCT07130734
Recruiting
Digital Intervention for Physical Activity
Not applicable · United States · 1 site
Registry update: 28 Oct 2026
NCT07585981
Recruiting
Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Not applicable · China · 1 site
Registry update: 14 May 2026
NCT07112066
Recruiting
Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
Not applicable · Switzerland · 1 site
Registry update: 9 Dec 2025
NCT07276867
Recruiting
Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity
Not applicable · Egypt · 1 site
Registry update: 11 Dec 2025
NCT07588360
Recruiting
Haplo-Cord HSCT for AML/MDS
Not applicable · China · 4 sites
Registry update: 10 Jun 2026
NCT07906769
Recruiting
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Not applicable · Italy · 1 site
Registry update: 3 Nov 2026
NCT06599411
Recruiting
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
Not applicable · France · 1 site
Registry update: 12 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.